|
HS Code |
896320 |
| Productname | (S,S)-(-)-2,2'-Isopropylidenebis(4-Tert-Butyl-2-Oxazoline) |
| Casnumber | 162340-98-1 |
| Molecularformula | C19H32N2O2 |
| Molecularweight | 320.47 |
| Appearance | White to off-white solid |
| Meltingpoint | 144-146°C |
| Opticalrotation | [α]D25 -106° (c=1, CHCl3) |
| Purity | Typically ≥98% |
| Solubility | Soluble in common organic solvents (e.g., dichloromethane, chloroform) |
| Storageconditions | Store at 2-8°C, protected from light and moisture |
| Chirality | Chiral, (S,S) enantiomer |
| Synonyms | (S,S)-iPrBox, (S,S)-4-tert-Butyl-2,2'-isopropylidenebis(2-oxazoline) |
| Smiles | CC(C)C1=NC(C(C)(C)C)CO1.CC(C)C2=NC(C(C)(C)C)CO2 |
| Inchikey | ZPSHFSYCIYJCSS-DHZHZOJOSA-N |
As an accredited (S,S)-(-)-2,2'-Isopropylidenebis(4-Tert-Butyl-2-Oxazoline) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical is packaged in a 25-gram amber glass bottle, sealed with a blue screw cap and labeled with product and hazard information. |
| Shipping | This chemical, (S,S)-(-)-2,2'-Isopropylidenebis(4-Tert-Butyl-2-Oxazoline), is shipped in tightly sealed containers to prevent moisture and air exposure. It is packed according to safety regulations for stable organic compounds and delivered via accredited chemical couriers, ensuring compliance with all relevant transportation and handling guidelines. |
| Storage | Store **(S,S)-(-)-2,2'-Isopropylidenebis(4-tert-butyl-2-oxazoline)** in a tightly sealed container under an inert atmosphere, such as nitrogen or argon, to prevent moisture or air exposure. Keep it in a cool, dry place away from sources of heat and direct sunlight. Recommended storage temperature is typically between 2-8°C (refrigerated conditions). Always follow applicable chemical safety protocols. |
Applications of (S,S)-(-)-2,2'-Isopropylidenebis(4-Tert-Butyl-2-Oxazoline) in Industrial ManufacturingAs the original manufacturer, we supply this high-purity bis(oxazoline) chiral ligand to strategic partners in demanding technology fields. We support advanced production needs by providing tailored specifications for high-performance catalysts and specialty polymer industries. Below are real, high-value applications where our raw material delivers consistent results and production value. 1. Asymmetric Catalysis for Pharmaceutical IntermediatesThis oxazoline compound operates as a chiral ligand in transition metal complexes, widely adopted in enantioselective catalytic processes such as asymmetric cyclopropanation, Michael addition, and allylic alkylation. Major pharmaceutical companies use it for active pharmaceutical ingredient (API) synthesis, enabling efficient generation of single-enantiomer intermediates. Typical integration points include Rhodium(I), Copper(II), and Nickel(II) catalyst systems, where precise ligand-to-metal ratios drive both selectivity and yield. Equipment validation under GMP protocols remains critical prior to batch production. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Regioselective Polymerization for Functional MaterialsLeading material manufacturers deploy this compound as a ligand modulator for late transition metal catalysts in controlled polymerization. The steric and electronic properties significantly influence tacticity, molecular weight, and end-product uniformity of specialty polymers, including block copolymers and high-performance engineering plastics. We supply product with trace metal controls to meet downstream polymerization QC standards and prevent microgel formation. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Chiral Stationary Phases in HPLC Column ProductionOEM analytical equipment suppliers utilize (S,S)-(-)-2,2'-Isopropylidenebis(4-Tert-Butyl-2-Oxazoline) for covalent bonding onto silica gel substrates to create high-performance chiral stationary phases. These phases enable precise quantitative separation of enantiomers in industrial QC and pharmaceutical validation workflows. Surface loading, silanization ratios, and post-treatment routines remain customer-specific and are verified under column testing protocols. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Ligand Development for Complex Olefin TransformationsFine chemical producers employ this molecule as a key ligand for transition metal-catalyzed cycloaddition, cyclopropanation, and hydroformylation reactions. Its bulky tert-butyl substituents and rigid structure enhance selectivity and conversion in feedstock upgrading and high-cycle operations. Strict batch traceability and impurity profiling enable compliance during scale-up and continuous plant commissioning. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Specialty Resins for High-Performance CoatingsLeading resin manufacturers integrate the compound during synthesis of engineered epoxy and acrylate systems that require specific optical activity and molecular geometry for end-use in high-end coatings. Elementary feed mixing and precise batch temperature controls avoid premature cross-linking, while rigorous 100% raw material traceability supports audit trails and downstream certification processes. Our product supports advancements in UV-curable formulations where chiral selectors enhance film homogeneity. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive (S,S)-(-)-2,2'-Isopropylidenebis(4-Tert-Butyl-2-Oxazoline) prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
On the production floor, it’s easy to recognize the significance of chemical structure to downstream results. Among the range of ligands for asymmetric catalysis, (S,S)-(-)-2,2'-Isopropylidenebis(4-tert-butyl-2-oxazoline) stands out for its chiral induction strength and solid reliability. Operators and chemists always appreciate raw material that keeps batches reproducible, and this compound consistently delivers that level of control. Over years of synthesis, its performance in asymmetric transition metal catalysis keeps drawing real applied interest, especially from researchers moving into more selective or stereoselective syntheses.
We set up the model as (S,S)-(-)-iPrBox-(tBu), produced within close control of enantiomeric purity and physical specs. Every bottle comes off the line after batch-specific HPLC and NMR checks to verify enantiomeric excess and absence of contaminants. Color, melting range, and solubility consistently reflect defined targets, since variations in purity or residual water can throw a wrench into catalytic runs.
Our team initially faced minor issues with ring-opened byproduct formation during scale-up, particularly when ambient humidity ran high or solvents showed trace protic scavenging. Tightening up drying and purification gave results in both overall yield and product consistency. When the lab developed our latest protocol, they focused on temperature and solvent parameters, maintaining a finely tuned isopropylidene ketal formation. Each parameter shift ripples through yield and stereopurity, so line workers track and log deviations and trends, trying to nip recurrence in the bud.
Daily reality on the manufacturing line differs from a literature recipe. Operators need smooth, manageable handling—so we target product that refuses to cake, clump, or show static buildup at transfer points. Worker feedback drove us to implement anti-static measures and improved grinding before bottling, since small process changes often cut waste by more than any automation tweak. Right particle size represents more than a box to check—it gives steady measuring and prevents frustration on the user side.
This oxazoline carries a clear, crystalline solid form, melting in a reproducible temperature window. Strong steric bulk from the tert-butyl groups translates into both thermal stability and handling advantages. Technicians appreciate its low volatility, which means minimal material loss or risk during weighing and transfer. On the chemical level, the isopropylidene center knots together two oxazoline rings to craft a rigid, predictable chelating backbone—a requirement for demanding asymmetric transformations.
While others use chiral bis-oxazoline ligands with smaller alkyl groups, (S,S)-(-)-2,2'-isopropylidenebis(4-tert-butyl-2-oxazoline) brings a bulkier package to the metal center. This shifts the selectivity profile in many catalyzed steps, sometimes blocking undesired reaction pathways with its pronounced steric shield. Chemists repeating enantioselective cyclopropanations, Diels–Alder, or allylic oxidations report notably high asymmetric induction compared to ligands with less hindered backbone designs.
Within chiral ligand design, small differences produce large shifts in catalytic outcome. Years of running asymmetric transition metal complexes underline that. Our oxazoline showcases its strengths in copper, iron, nickel, and palladium-catalyzed settings. Reactions that stumbled with more flexible ligands, or with uncontrolled side products, now show tight enantioselectivity. Pharmas doing pilot scale or specialty synthesis consistently highlight its value in delivering clean chiral centers, a make-or-break requirement for regulatory approval and formulation work. Reproducible enantioselectivity translates into fewer failed batches, tighter release windows, and significant cost control.
Process chemists use this backbone for various transformations—cyclopropanation, aziridination, allylic alkylation, and more. Its molecular configuration carries the (S,S) chirality, forming dications with transition metals that command precise geometry at the active site. That’s not just academic precision; a twist or flex in the ligand, or a wrong enantiomer, can mean wasted reagents or weeks of cleanup downstream.
With the tert-butyl groups located at the 4-position of the oxazoline rings, steric control pushes reactions to higher enantioselectivity in most published reactions. Some groups even report better yields with this ligand than less encumbered versions, which tend to produce more racemate in similar copper-catalyzed or palladium-mediated processes.
Direct comparisons with classic bis(oxazoline) ligands highlight real-world distinctions. Smaller alkyl groups, such as methyl or ethyl derivations, deliver more flexible chelate rings—fine for some broad-brush reactions but less decisive in limiting unproductive metal binding. Once we switched protocols to use the tert-butyl-substituted variant for a customer’s pharma project, the downstream purification saw a jump in both chiral purity and speed.
Bulkier tert-butyl arms also help minimize air and moisture interaction during setup and run-up. This proves especially helpful in open-vessel bench reactions, where environmental drift wastes not only time but expensive metal catalysts. Our team noticed over multiple batches that the (S,S) tert-butyl variant often retained better color stability and less decomposition, even weeks after opening under controlled storage.
An added practical note on safety—handling any bis(oxazoline) compound involves standard protective practice. Technicians prefer our crystalline material because it resists dust formation far more than loose powders or amorphous solids. Less dust means less exposure at the bench and far simpler decontamination at shift close.
The push for efficiency and selectivity in synthetic pathways keeps gaining ground. From hands-on chemists running weekly campaigns to R&D groups pushing green chemistry, nobody underestimates the value of a reliable ligand. Through cycles of batch feedback, our production team fine-tunes product consistency, as process partners emphasize reproducibility in both lab and industrial environments.
In practice, chemists draw on the strengths of this compound to streamline chiral auxiliary assembly. They report short workup and lighter post-reaction purification, linking measurable cost and time savings directly to ligand selection. End users in pilot scale development highlight that each percentage point in enantiomeric excess often saves several days by reducing the number of chromatographic passes needed for purification. That kind of efficiency never goes unnoticed on a busy bench.
Laboratory reports point out that projects with newer or more sensitive pharmaceuticals frequently require not just high yield but minimal metal contamination and predictable batch-to-batch results. Our material stands up to these requirements by coming clean through QC and keeping batch variance well within spec. Years ago, minor solvent carrying caused demand for a new QC step; firsthand customer feedback led to new drying and packaging procedures—one direct result of manufacturer-end experience guiding tangible change.
Bis(oxazoline) ligands, or BOX ligands, form five-membered chelate rings with transition metals, fixing both the stereo configuration and the open coordination sites available for substrate binding. The isopropylidene bridge in (S,S)-(-)-2,2'-Isopropylidenebis(4-tert-butyl-2-oxazoline) holds the two oxazoline rings in a rigid saddle, which shapes the spatial approach for catalytic transformations.
Spending time on real reactor runs teaches a valuable lesson—small changes in ligand flexibility or symmetry often translate into dramatic differences in selectivity outcomes. In several contract projects, customers using a more flexible (S,S)-bis(oxazoline) variant saw higher byproduct ratios and more variable results. Following a transition to the tert-butyl, isopropylidene bridge ligand, they reported both cleaner conversions and easier scalability.
Users highlight easier solution preparation and reproducible complexation kinetics with transition metals. That behavior follows from the hydrophobic and crystal-pure character of our batches, which limits water uptake and discourages side decomposition. With every kilogram batch, QA staff run full water content assessments and colorimetric checks, building a track record of reliability that competitors notice.
Each scale-up attempt brings a unique challenge. Pharmaceutical teams project the cost of goods, waste solvents, and purification steps. Here, the quality of the chiral ligand affects more than the initial step—side reactions, intermediate colorants, or poor catalyst retention all mean remedial work, lost time, and margin slip. Using the (S,S)-(-)-2,2'-isopropylidenebis(4-tert-butyl-2-oxazoline) ligand mitigates wild swings in batch outcomes.
On a 100-gram to kilogram scale, suppliers often cut corners on drying or crystal sizing, betting the end user will clean up the material before use. We’ve learned that predictable handling and solubility save far more headache and wasted time than the cost of running tight process controls.
Users needing large runs for pilot plant catalysis or active pharmaceutical ingredient (API) steps prefer our crystalline, dust-free stock. We reject any portion that fails meltdown, solubility, or color threshold, focusing on only the brightest, purest product for end users. Operators coordinate with customer support to tweak shipment conditions if environmental swings or transit time threaten critical stability or hydration state. This cooperation closes the feedback loop, sharpening both production and real-world application.
Safe and practical handling marks every process step. Factory workers benefit from our dry, non-caking powder—A less manageable, sticky, or static-prone material always slows transfer, sometimes risking spills or wasted time. Storage in sealed, moisture-resistant containers ensures lots stay dry and flowable. Years of tightening up humidity-related spoilage contributed to our current process, which draws on both operator reports and customer audits.
Standard lab gloves, goggles, and dust masks suffice for direct handling; unlike some oxazoline analogs, user reports reflect less dust and less airborne risk. Chemists scaling reactions give positive feedback on consistent weighing, solution preparation, and simple container decontamination after use.
Research and production teams gravitate toward (S,S)-(-)-2,2'-isopropylidenebis(4-tert-butyl-2-oxazoline) for its broad scope in stereoselective transformations. At pilot and intermediate plant scales, shorter reaction times and fast ligand recovery drive down per-batch costs, critical for tight-margin or regulatory-bound runs. The ligand’s selectivity often means greater throughput for the same equipment compared to less demanding ligands, shifting overall resource efficiency.
The most frequent applications arise in asymmetric cyclopropanation, copper-catalyzed aziridination, and palladium-catalyzed allylic alkylation. Literature applications keep expanding, not just in pharmaceuticals but also in fragrance, agrochemical, and fine specialty sectors. As process teams push for greener chemistries, this ligand finds favor for enabling milder, scaleable methods, often skipping hazardous chiral auxiliaries or heavy metal scavenging.
As more industries migrate to high-throughput, data-driven screening, the premium on batch-to-batch reproducibility grows steeper. Buyers tell us they rely on our control methods to lock in key physical and stereochemical parameters, confident in the workup and chiral HPLC data behind each lot. Our production crew takes pride not just in crystal clarity, but in helping deliver high-yield, low-waste syntheses without hidden pitfalls.
The confidence that a reaction will progress as expected, not stall, or throw off surprises drives much of our design and QC focus. That trust means end-users can invest in multi-step syntheses, expanding the possible complexity of targets achievable within demanding regulatory review timelines.
Today’s supply chains face increasing pressure to track ingredient provenance and minimize impurity carryover. From procurement through to final bottling, each production phase incorporates both documentation and traceable analytical data. Direct communication with user groups, both academic and industrial, keeps us tuned to upcoming changes in safety, environmental, and traceability requirements. That philosophy influences our sourcing, analytical, and shipping protocols.
Regular audits challenge us to keep both the letter and intent of regulations at the center of process design. By keeping technical and production teams working in step, we minimize waste and prevent contamination, fulfilling broader sustainability goals as clients demand. Our protocols evolve through direct engagement—tracing user problems back to their root and implementing practical tweaks instead of temporary workarounds.
Handling, synthesizing, bottling, and shipping (S,S)-(-)-2,2'-isopropylidenebis(4-tert-butyl-2-oxazoline) for years teaches that small decisions early in manufacture echo throughout the product’s life. The best affirmation comes from repeat customers reporting cleaner, more predictable results and tighter margins on process control. As the application spaces for chiral ligands expand, feedback from every end user guides iterative process improvement, shaping a more robust and sustainable product for the next set of synthetic challenges.